Major Shift in Demand For HIV Diagnostics Market – New Study For 2021
Rising number of HIV cases is expected to drive demand for HIV Diagnostics, which is further expected to augment the market growth over the forecast period. For instance, according to the Avert.org, the number of HIV cases increased from 36.7 million to around 36.9 million globally, from the year 2016 and 2017 respectively. Moreover, according to the UNAIDS 2019 report, around 37.9 million of global people suffered from HIV in 2018. Increasing prevalence of HIV/AIDS globally and various government initiatives by countries to spread awareness about HIV in people are expected to drive growth of the HIV diagnostic market. Regions with lower literacy rate, where people are not aware about transmission mode of HIV, changing lifestyle, and unsafe sex are the factors that leads to increasing number of HIV cases. Get More Insights (at) https://www.coherentmarketinsights.com/market-insight/hiv-diagnostics-market-422
Rising number of HIV cases is expected to drive demand for HIV Diagnostics, which is further expected to augment the market growth over the forecast period. For instance, according to the Avert.org, the number of HIV cases increased from 36.7 million to around 36.9 million globally, from the year 2016 and 2017 respectively. Moreover, according to the UNAIDS 2019 report, around 37.9 million of global people suffered from HIV in 2018.
Increasing prevalence of HIV/AIDS globally and various government initiatives by countries to spread awareness about HIV in people are expected to drive growth of the HIV diagnostic market. Regions with lower literacy rate, where people are not aware about transmission mode of HIV, changing lifestyle, and unsafe sex are the factors that leads to increasing number of HIV cases.
Get More Insights (at) https://www.coherentmarketinsights.com/market-insight/hiv-diagnostics-market-422
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>HIV</strong><br />
DIAGNOSTICS<br />
MARKET<br />
<strong>Market</strong> Size (2018)<br />
US$ 3,050.8<br />
MN<br />
CAGR (2019<strong>–</strong><br />
2027)<br />
9.2%<br />
© Coherent <strong>Market</strong> Insights. All Rights Reserved
Segmentation (Scope)<br />
By Product Type<br />
‣ Instruments<br />
‣ Kits and Reagents<br />
By End User<br />
‣ Hospital & Cl<strong>in</strong>ics<br />
‣ Diagnostic Laboratories<br />
‣ Home Care Sett<strong>in</strong>gs<br />
‣ Others<br />
By Region<br />
‣ North America<br />
‣ Lat<strong>in</strong> America<br />
‣ Europe<br />
‣ Asia Pacific<br />
‣ Middle East<br />
‣ Africa<br />
By Test Type<br />
‣ Instruments<br />
Third Generation (Antibody Test)<br />
• Laboratoy-based<br />
• Po<strong>in</strong>t-of-Care<br />
Fourth Generation (Antibody-Antigen (Ab/Ag) Test)<br />
• Laboratoy-based<br />
• Po<strong>in</strong>t-of-Care<br />
Others<br />
‣ Differentiation & Confirmation Test<br />
‣ Monitor<strong>in</strong>g Test<br />
<br />
<br />
CD4 Tests<br />
Viral Load Tests<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
<strong>Major</strong> Drivers<br />
<br />
Ris<strong>in</strong>g government<br />
<strong>in</strong>itiatives and<br />
programs for<br />
controll<strong>in</strong>g <strong>HIV</strong><br />
<strong>in</strong>fection<br />
<br />
Ris<strong>in</strong>g adoption of<br />
merger and<br />
acquisition<br />
strategies by the<br />
market players<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
NORTH<br />
AMERICA<br />
<strong>Market</strong> Size<br />
US$ 1,159.3 MN<br />
<strong>Major</strong> Drivers<br />
Increas<strong>in</strong>g prevalence of <strong>HIV</strong> <strong>in</strong>fection<br />
Ris<strong>in</strong>g number of product launch<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
<strong>Major</strong><br />
Players<br />
Abbott Laboratories<br />
Bio-Rad Laboratories, Inc.<br />
Hologic, Inc.<br />
Siemens Health<strong>in</strong>eers<br />
Roche AG<br />
Beckman Coulter Inc.<br />
OraSure Technologies, Inc.<br />
Becton, Dick<strong>in</strong>son and Company<br />
Merck KGaA<br />
Chembio Diagnostic System, Inc.<br />
Zyomyx Incorporation<br />
Bristol <strong>–</strong>Myres Squibb<br />
Janssen Therapeutic<br />
QIAGEN N.V.<br />
ViiV Healthcare Ltd.<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
Global <strong>HIV</strong> <strong>Diagnostics</strong> <strong>Market</strong> Share (%),<br />
By Product Type, 2019 and 2027<br />
64.4%<br />
2019 2027<br />
?<br />
?<br />
?<br />
Instruments<br />
Reagents<br />
and Kits<br />
Instruments<br />
Reagents<br />
and Kits<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
Change language